Showing results (271-280 of 536) with videos related to

Sort By:
Pageof 54
Current Opinion in Pharmacology|July 23, 2013
Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular diseaseMicheal S Ward, Amelia K Fortheringham, Mark E Cooper, et al.
Current Pharmaceutical Design|November 17, 2004
Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathyJosephine M Forbes, Vicki Thallas-Bonke, Mark E Cooper, et al.
Circulation Research|June 23, 2020
Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting MyelopoiesisMichelle C Flynn, Michael J Kraakman, Christos Tikellis, et al.
Journal of Hypertension|January 12, 2005
Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin systemBishoy Rizkalla, Josephine M Forbes, Zemin Cao, et al.
Nature Reviews. Drug Discovery|May 1, 2009
Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trialsNigel A Calcutt, Mark E Cooper, Tim S Kern, et al.
Epilepsia|May 11, 2019
Genomic DNA methylation distinguishes subtypes of human focal cortical dysplasiaKatja Kobow, Mark Ziemann, Harikrishnan Kaipananickal, et al.
The Canadian Journal of Cardiology|May 8, 2018
Pathophysiological Links Between Diabetes and Blood PressureRenata Libianto, Duygu Batu, Richard J MacIsaac, et al.
Clinical Science (London, England : 1979)|August 14, 2024
To target cellular senescence in diabetic kidney disease: the known and the unknownYuehan Wei, Shan Mou, Qing Yang, et al.
American Journal of Physiology. Renal Physiology|January 31, 2014
Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetesChris Tikellis, Russel Brown, Geoffrey A Head, et al.
Pageof 54